List of Excipients in API hydralazine hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing hydralazine hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Azurity | BIDIL | hydralazine hydrochloride and isosorbide dinitrate | 24338-010 | ALUMINUM OXIDE | |
| Azurity | BIDIL | hydralazine hydrochloride and isosorbide dinitrate | 24338-010 | ANHYDROUS LACTOSE | |
| Azurity | BIDIL | hydralazine hydrochloride and isosorbide dinitrate | 24338-010 | CELLULOSE, MICROCRYSTALLINE | |
| Azurity | BIDIL | hydralazine hydrochloride and isosorbide dinitrate | 24338-010 | FD&C YELLOW NO. 6 | |
| Azurity | BIDIL | hydralazine hydrochloride and isosorbide dinitrate | 24338-010 | HYPROMELLOSE | |
| Azurity | BIDIL | hydralazine hydrochloride and isosorbide dinitrate | 24338-010 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing hydralazine hydrochloride
Detailed excipient profiles for hydralazine hydrochloride
Excipient focus: ALUMINUM OXIDE
hydralazine hydrochloride drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Aphena Pharma Solutions - Tennessee LLC | hydralazine hydrochloride | 43353-124 |
| Azurity | hydralazine hydrochloride and isosorbide dinitrate | 24338-010 |
| >Company | >Ingredient | >NDC |
hydralazine hydrochloride drug variants not containing ALUMINUM OXIDE
Excipient focus: ANHYDROUS LACTOSE
hydralazine hydrochloride drug variants containing ANHYDROUS LACTOSE
hydralazine hydrochloride drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
hydralazine hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
hydralazine hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: FD&C RED NO. 40
hydralazine hydrochloride drug variants containing FD&C RED NO. 40
hydralazine hydrochloride drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
hydralazine hydrochloride drug variants containing FD&C YELLOW NO. 6
hydralazine hydrochloride drug variants not containing FD&C YELLOW NO. 6
Excipient focus: HYDROCHLORIC ACID
hydralazine hydrochloride drug variants containing HYDROCHLORIC ACID
hydralazine hydrochloride drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYPROMELLOSE
hydralazine hydrochloride drug variants containing HYPROMELLOSE
hydralazine hydrochloride drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSES
hydralazine hydrochloride drug variants containing HYPROMELLOSES
hydralazine hydrochloride drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE
hydralazine hydrochloride drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | hydralazine hydrochloride | 0615-0516 |
| >Company | >Ingredient | >NDC |
hydralazine hydrochloride drug variants not containing LACTOSE
Excipient focus: LIGHT MINERAL OIL
hydralazine hydrochloride drug variants containing LIGHT MINERAL OIL
hydralazine hydrochloride drug variants not containing LIGHT MINERAL OIL
Excipient focus: MAGNESIUM STEARATE
hydralazine hydrochloride drug variants containing MAGNESIUM STEARATE
hydralazine hydrochloride drug variants not containing MAGNESIUM STEARATE
Excipient focus: MANNITOL
hydralazine hydrochloride drug variants containing MANNITOL
hydralazine hydrochloride drug variants not containing MANNITOL
Excipient focus: METHYLPARABEN
hydralazine hydrochloride drug variants containing METHYLPARABEN
hydralazine hydrochloride drug variants not containing METHYLPARABEN
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
hydralazine hydrochloride drug variants containing MICROCRYSTALLINE CELLULOSE 102
hydralazine hydrochloride drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: MICROCRYSTALLINE CELLULOSE 105
hydralazine hydrochloride drug variants containing MICROCRYSTALLINE CELLULOSE 105
hydralazine hydrochloride drug variants not containing MICROCRYSTALLINE CELLULOSE 105
Excipient focus: MINERAL OIL
hydralazine hydrochloride drug variants containing MINERAL OIL
hydralazine hydrochloride drug variants not containing MINERAL OIL
Excipient focus: POLYETHYLENE GLYCOL
hydralazine hydrochloride drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Azurity | hydralazine hydrochloride and isosorbide dinitrate | 24338-010 |
| Wilshire Pharmaceuticals | hydralazine hydrochloride and isosorbide dinitrate | 52536-006 |
| >Company | >Ingredient | >NDC |
hydralazine hydrochloride drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYSORBATE 80
hydralazine hydrochloride drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Azurity | hydralazine hydrochloride and isosorbide dinitrate | 24338-010 |
| Wilshire Pharmaceuticals | hydralazine hydrochloride and isosorbide dinitrate | 52536-006 |
| >Company | >Ingredient | >NDC |
hydralazine hydrochloride drug variants not containing POLYSORBATE 80
Excipient focus: POVIDONE K30
hydralazine hydrochloride drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | hydralazine hydrochloride | 67877-293 |
| >Company | >Ingredient | >NDC |
hydralazine hydrochloride drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
hydralazine hydrochloride drug variants containing PROPYLENE GLYCOL
hydralazine hydrochloride drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
hydralazine hydrochloride drug variants containing PROPYLPARABEN
hydralazine hydrochloride drug variants not containing PROPYLPARABEN
Excipient focus: SILICON DIOXIDE
hydralazine hydrochloride drug variants containing SILICON DIOXIDE
hydralazine hydrochloride drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM HYDROXIDE
hydralazine hydrochloride drug variants containing SODIUM HYDROXIDE
hydralazine hydrochloride drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURYL SULFATE
hydralazine hydrochloride drug variants containing SODIUM LAURYL SULFATE
hydralazine hydrochloride drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
hydralazine hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
hydralazine hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
hydralazine hydrochloride drug variants containing STARCH, CORN
hydralazine hydrochloride drug variants not containing STARCH, CORN
Excipient focus: STEARIC ACID
hydralazine hydrochloride drug variants containing STEARIC ACID
hydralazine hydrochloride drug variants not containing STEARIC ACID
Excipient focus: TITANIUM DIOXIDE
hydralazine hydrochloride drug variants containing TITANIUM DIOXIDE
hydralazine hydrochloride drug variants not containing TITANIUM DIOXIDE
Excipient focus: WATER
hydralazine hydrochloride drug variants containing WATER
hydralazine hydrochloride drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
